The Multiple Myeloma Market should see a stand-out year in 2

The global multiple myeloma market size is projected to reach USD 31 billion by the end of 2026. The high prevalence of the disease will emerge in favor of the companies operating in the market. According to a report published by Fortune Business Insights, titled “Multiple Myeloma Market Size, Share & Industry Analysis, By Drug Class (Immunomodulators, Proteasome Inhibitor, Anti-CD38 Monoclonal Antibody, Alkylating Agents, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies), and Regional Forecast, 2019-2026,” the market was worth USD 19.48 billion in 2018 and will exhibit a CAGR of 6.0% during the forecast period, 2019-2026.



​



Click here to get the short-term and long-term impact of COVID-19 on this Multiple Myeloma Market.



Please visit: www.fortunebusinessinsights.com/multiple-myeloma-market-102693


Detailed Table of Content:







Introduction

Research Scope

Market Segmentation

Research Methodology

Definitions and Assumptions

Executive Summary

Market Dynamics

Market Drivers

Market Restraints

Market Opportunities

Key Insights

Prevalence of Multiple Myeloma - by Key Countries - 2018

Pipeline Analysis

Key Industry Developments

Regulatory Scenario, by Key Regions

Analysis Of Economic Burden of Multiple Myeloma Treatment

New Product Launches

Overview of Emerging Treatments for Multiple Myeloma

Global Multiple Myeloma Market Analysis, Insights and Forecast, 2015-2026

Key Findings / Summary

Market Analysis, Insights and Forecast – By Drug Class

Immunomodulators

Proteasome Inhibitor

Anti-CD38 Monoclonal Antibody

Alkylating Agents

Others

Market Analysis, Insights and Forecast – By Distribution Channel

Hospital Pharmacies

Retail Pharmacies & Drug Stores

Online Pharmacies

Market Analysis, Insights and Forecast – By Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa